About Suzhou Fushilai Pharmaceutical Company

The company mainly produces three major products: lipoic acid series, carnosine series, and phosphatidylcholine series, all of which are encouraged “biomedical” high-tech products. The product is mainly used in medicine, dietary supplements, cosmetics, etc., and has remarkable effects in anti-oxidation, delaying aging, and relieving diabetic neuropathy. The products are mainly exported, and have been exported to foreign markets such as Europe, America, Southeast Asia, etc., and the domestic market share of lipoic acid raw materials is among the highest, and long-term strategic cooperative relationships have been established with important domestic and foreign customers. The company focuses on R&D, production and sales of pharmaceutical intermediates, APIs and raw materials for health products. The main products include three series of products, including lipoic acid series, phosphatidylcholine series, and carnosine series. Main products: Lipoic acid series, phosphatidylcholine series, carnosine series. Company honors: Production Safety Standardization Certificate, Jiangsu Science and Technology Little Giant Enterprise, Food Business License, High-tech Enterprise, People's Republic of China Pharmaceutical Production License, Environmental Management System Certification Certificate, High-tech Enterprise, Changshu City Excellent Group Caring for the Next Generation of Jobs, etc.